B ‐cell reconstitution is strongly associated with COVID‐19 vaccine responsiveness in rheumatic disease patients treated with rituximab
ConclusionsB-cell reconstitution and longer time from last rituximab exposure were associated with a positive serologic response to the COVID-19 vaccine. Strategies for maximizing vaccine responsiveness in rituximab treated patients should incorporate assessment of B-cell reconstitution.This article is protected by copyright. All rights reserved.
Source: Arthritis and Rheumatology - Category: Rheumatology Authors: Sarah Jinich,
Kaitlin Schultz,
Deanna Jannat ‐Khah,
Robert Spiera Tags: Brief Report Source Type: research